| Primary | Urinary Protein/Creatinine Ratio at Week 52 [LOCF] | Urinary protein/creatinine ratio (mg/g) =urine protein concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 52 [LOCF] urine protein/creatinine ratio over baseline urine protein/creatinine ratio. | | Posted | | Geometric Mean | 95% Confidence Interval | ratio | | Assessed at baseline and Week 52 (LOCF) | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin 10 mg | | | OG001 | Rosuvastatin 40 mg | | | OG002 | Atorvastatin 80 mg | |
| | | Title | Denominators | Categories |
|---|
| | | Title | Measurements |
|---|
| - OG0000.938(0.725 to 1.212)
- OG0011.082(0.927 to 1.262)
- OG0020.759(0.636 to 0.905)
|
|
| |
| Secondary | Urinary Protein/Creatinine Ratio at Week 26. | Urinary protein/creatinine ratio (mg/g) =urine protein concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 26 urine protein/creatinine ratio over baseline urine protein/creatinine ratio. | | Posted | | Geometric Mean | 95% Confidence Interval | ratio | | Assessed at baseline and Week 26 | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin 10 mg | | | OG001 | Rosuvastatin 40 mg | | | OG002 | Atorvastatin 80 mg | |
| |
| Secondary | Urinary Albumin/Creatinine Ratio at Week 26 | Urinary albumin/creatinine ratio (mg/g) =urine albumin concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 26 urine albumin/creatinine ratio over baseline urine albumin/creatinine ratio. | | Posted | | Geometric Mean | 95% Confidence Interval | ratio | | Assessed at baseline and Week 26 | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin 10 mg | | | OG001 | Rosuvastatin 40 mg | | | OG002 | Atorvastatin 80 mg | |
| |
| Secondary | Urinary Albumin/Creatinine Ratio at Week 52 [LOCF] | Urinary albumin/creatinine ratio (mg/g) =urine albumin concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 52 [LOCF] urine albumin/creatinine ratio over baseline urine albumin/creatinine ratio. | | Posted | | Geometric Mean | 95% Confidence Interval | ratio | | Assessed at baseline and Week 52 [LOCF] | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin 10 mg | | | OG001 | Rosuvastatin 40 mg | | | OG002 | Atorvastatin 80 mg | |
| |
| Secondary | Change From Baseline in Estimated Glomerular Filtration Rate (eGFR) at Week 26 | The change from baseline in eGFR at Week 26 is the Week 26 value minus baseline value. | | Posted | | Mean | Standard Deviation | mL/min | | Assessed at baseline and Week 26 | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin 10 mg | | | OG001 | Rosuvastatin 40 mg | | | OG002 | Atorvastatin 80 mg | |
| |
| Secondary | Change From Baseline in eGFR at Week 52 [LOCF] | The change from baseline in eGFR at Week 52 [LOCF] is the Week 52 value or last observation carried forward minus baseline value. | | Posted | | Mean | Standard Deviation | mL/min | | Assessed at baseline and Week 52 [LOCF] | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin 10 mg | | | OG001 | Rosuvastatin 40 mg | | | OG002 | Atorvastatin 80 mg | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in Total Cholesterol [TC] at Week 26. | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in Total Cholesterol [TC] at Week 52. | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline inUrinary Protein/Creatinine Ratio With Percent Change From Baseline in LDL-C | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in High Density Lipoprotein Cholesterol [HDL-C] at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in HDL-C at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in Non-high Density Lipoprotein Cholesterol [nonHDL-C] at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship. ) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in nonHDL-C at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in Triglyceride [TG] at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in TG at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in TC/HDL-C Ratio at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in TC/HDL-C Ratio at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in LDL-C/HDL-C Ratio at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in LDL-C/HDL-C Ratio at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in nonHDL-C/HDL-C Ratio at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in nonHDL-C/HDL-C Ratio at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in Apolipoprotein A-1 [ApoA-1] at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in ApoA-1 at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in Apolipoprotein B [ApoB] at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in ApoB at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in ApoB/ApoA-1 Ratio at Week 26 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Protein/Creatinine Ratio With Percent Change From Baseline in ApoB/ApoA-1 Ratio at Week 52 | Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in TC at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in TC at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in LDL-C at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in LDL-C at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in HDL-C at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in HDL-C at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in nonHDL-C at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in nonHDL-C at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in TG at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in TG at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in TC/HDL-C Ratio at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in TC/HDL-C Ratio at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in LDL-C/HDL-C Ratio at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in LDL-C/HDL-C Ratio at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in nonHDL-C/HDL-C Ratio at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in nonHDL-C/HDL-C Ratio at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in ApoA-1 at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in ApoA-1 at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in ApoB at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in ApoB at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in ApoB/ApoA-1 Ratio at Week 26 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in Urinary Albumin/Creatinine Ratio With Percent Change From Baseline in ApoB/ApoA-1 Ratio at Week 52 | Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in eGFR With Percent Change From Baseline in TC at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in eGFR With Percent Change From Baseline in TC at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in eGFR With Percent Change From Baseline in LDL-C at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in eGFR With Percent Change From Baseline in LDL-C at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in eGFR With Percent Change From Baseline in HDL-C at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Changes From Baseline in eGFR With Percent Change From Baseline in HDL-C at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in nonHDL-C at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in nonHDL-C at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in TG at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in TG | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in TC/HDL-C Ratio at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in TC/HDL-C Ratio at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in LDL-C/HDL-C Ratio at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in LDL-C/HDL-C Ratio at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in nonHDL-C/HDL-C Ratio at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in nonHDL-C/HDL-C Ratio at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in ApoA1 at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in ApoA1 at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in ApoB at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in ApoB at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in ApoB/ApoA-1 Ratio at Week 26 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 26 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |
| Secondary | Correlation of Change From Baseline in eGFR With Percent Change From Baseline in ApoB/ApoA-1 Ratio at Week 52 | Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52. (Correlation values range from -1 to +1. -1 indicates a perfect negative linear relationship while a +1 indicates a perfect linear positive relationship. A value of zero indicates no relationship.) | | Posted | | Number | | Correlation coefficient | | Baseline and 52 weeks | | | | ID | Title | Description |
|---|
| OG000 | Rosuvastatin | Rosuvastatin Treatments pooled | | OG001 | Atorvastatin | | | OG002 | All Treatments | |
| |